CYCLOPHOSPHAMIDE for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 42 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE was used for Prostate cancer.
Most Reported Side Effects for CYCLOPHOSPHAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 12,578 | 9.8% | 2,788 | 3,928 |
| Febrile neutropenia | 11,318 | 8.8% | 1,348 | 7,223 |
| Drug ineffective | 8,142 | 6.3% | 2,157 | 2,184 |
| Neutropenia | 7,352 | 5.7% | 1,287 | 2,890 |
| Disease progression | 7,100 | 5.5% | 1,730 | 1,008 |
| Pyrexia | 6,126 | 4.8% | 832 | 4,228 |
| Product use in unapproved indication | 5,750 | 4.5% | 1,245 | 1,392 |
| Thrombocytopenia | 4,669 | 3.6% | 902 | 1,799 |
| Pneumonia | 4,595 | 3.6% | 1,633 | 2,604 |
| Nausea | 4,561 | 3.6% | 363 | 2,190 |
| Anaemia | 4,486 | 3.5% | 664 | 2,040 |
| Death | 4,270 | 3.3% | 4,260 | 453 |
| Sepsis | 4,041 | 3.1% | 2,077 | 1,841 |
| Myelosuppression | 3,603 | 2.8% | 209 | 1,796 |
| Diarrhoea | 3,602 | 2.8% | 566 | 1,861 |
Other Indications for CYCLOPHOSPHAMIDE
Diffuse large b-cell lymphoma (16,598)
Plasma cell myeloma (9,148)
Breast cancer (8,826)
Product used for unknown indication (8,261)
Acute lymphocytic leukaemia (5,495)
B-cell lymphoma (4,766)
Bone marrow conditioning regimen (4,485)
Non-hodgkin's lymphoma (3,805)
Chemotherapy (3,372)
Chronic lymphocytic leukaemia (3,085)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)